ライフサイエンスコーパス: MS

1 MS/MS evaluation of a set of randomly selected 210 metab

2 mparable with what obtained with multiple 1D MS/MS experiments targeted on each individual component

3 In this work, a 2D MS method is developed to characterize complex mixtures

4 , the amount of information obtained with 2D MS was comparable with what obtained with multiple 1D MS

5 that Glycoforest annotated an additional 50 MS/MS spectra overlooked during manual annotation.

6 Peptide sequencing after MS/MS fragmentation enabled the identification of 116 di

7 ommunities, for example, by portable ambient MS.

8 vra cells show the highest rhythmicity among MS neurons and fire with short burst duration (median, 3

9 We describe an MS-based HTS workflow that addresses these challenges.

10 experimental allergic encephalomyelitis (an MS animal model), and the disease suppression depended o

11 In conclusion, the results suggest an MS level relative to weight for having a low metabolic r

12 yndrome (CIS) to multiple sclerosis (MS) and MS activity and disability.

13 ntion times, isotopic patterns, full MS, and MS/MS spectra.

14 r lipid identification software annotations, MS-DIAL and Greazy.

15 S by sex, year of birth, age/vital status at MS diagnosis, and region of residence (county), resultin

16 However, the former requires desalting to be MS-compatible, and the latter requires fraction pooling

17 tructures of the compounds were confirmed by MS, FTIR &(1)H NMR; and their properties were characteri

18 onstrated that covalent labeling followed by MS markedly increased the predictive power of the integr

19 In a subset of cases (MS, n = 20; control, n = 10), expression of plasminogen

20 ped using large-scale bottom-up proteomic CE-MS data (5% ( approximately 0.8M) acetic acid as backgro

21 rbon fiber ionization mass spectrometry (CFI-MS), which uses a carbon fiber bundle as the ion source,

22 Here, we use ChAP-MS (chromatin affinity purification with mass spectromet

23 spectrometry (LC-MS) and gas chromatography-MS (GC-MS) data relative to labelling experiments.

24 etection- tandem mass spectrometry (HPLC-DAD-MS/MS) identified 29 phenolics belonging to phenolic aci

25 the first time, this study reports a ddHRMS/MS method capable of complementing existing quantitative

26 Changes in DeltaG degrees MS-CPET from either source had the same effect on the MS

27 was higher in in-line than in angled LS DESI MS.

28 Desorption ES ionization (DESI) MS has however transformed the study of tissue surfaces

29 Intraoperative DESI-MS analysis of tissue smears, ex vivo, can be inserted i

30 Our results suggest DESI-MS as a powerful approach for rapid serous ovarian cance

31 -catenin signaling in CNS vessels during EAE/MS partially restores functional BBB integrity and limit

32 er and the SCNPs can be well ionized via ESI MS, and the strong covalent cross-links are stable durin

33 ESI-MS/MS results showed that the isolated mannan oligomers,

34 xtraction cartridge prior to analysis by ESI-MS/MS in negative ion mode.

35 equimolar concentration library, the CaR-ESI-MS assay identified 100% of ligands with affinities >500

36 Microprobe CE-ESI-MS of <0.02% of the single-cell content allowed us to de

37 ueous ethanol and analyzed with UPLC-DAD-ESI-MS, HPLC-DAD, and NMR.

38 We report the LC-ESI-MS/MS determination of betaines in commercial flours of

39 Additionally, the coupling of ESI-MS with online laser irradiation has been successfully a

40 ectrospray ionization mass spectrometry (ESI-MS) assay and model membranes of defined composition, to

41 ectrospray ionization mass spectrometry (ESI-MS) in native conditions to study the influence of modif

42 ray ionization tandem mass spectrometry (ESI-MS/MS) method has been developed for the identification

43 al (COSY, NOESY, DOSY) NMR spectroscopy, ESI-MS, ion-mobility mass spectrometry (IM-MS), AFM, and TEM

44 ted using the DRILL interface coupled to ESI-MS along with an improved limit of detection (10-fold en

45 betacyanins were identified by HPLC-DAD-ESI/MS(n), 23 and 15 new compounds being described in yellow

46 ance Raman (RR), hydrogen-deuterium exchange MS (HDX-MS) methods, and molecular dynamics (MD).

47 the dynamic CNS damage hypothesis to explain MS heterogeneity.

48 A quantitative evaluation of the LC-FAIMS-MS method was performed giving limits of detection in th

49 tures detected in human urine using LC-FAIMS-MS was increased approximately threefold compared to LC-

50 romatography and mass spectrometry (LC-FAIMS-MS) is shown to enhance peak capacity for omics applicat

51 ng an alternative to the widely used GC (FID/MS) methodologies.

52 s accomplished in blood using time-of-flight MS with perfluoro coated Si-GLAD SALDI, by comparison to

53 /min) to accommodate both low- and high-flow MS ionization sources.

54 nternational diagnostic imaging criteria for MS are not necessarily helpful in distinguishing these t

55 nd therefore could be a treatment option for MS, because it combines features of immunomodulation wit

56 e biomolecules with different properties for MS analysis is advantageous.

57 reate internal tryptic peptide standards for MS as well as an intact protein bearing multiple linear

58 PBMCs from MS patients stimulated with a TLR-9 agonist showed reduc

59 Until now 2D FTICR MS afforded only a moderate resolution for precursor ion

60 cyclotron resonance mass spectrometry (FTICR MS).

61 es, retention times, isotopic patterns, full MS, and MS/MS spectra.

62 Obtaining the full MS/MS map for fragments and precursors of complex mixtur

63 onion puree has been investigated using a GC-MS fingerprinting approach.

64 e analysed using spectrophotometry-UV and GC-MS-SPME, respectively.

65 ometry (LC-MS) and gas chromatography-MS (GC-MS) data relative to labelling experiments.

66 Gas Chromatography - Mass Spectrometery (GC-MS) together with (13)C stable isotope-labelled glucose

67 Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (

68 ust gas chromatography-mass spectrometry (GC-MS) method for the simultaneous determination of propane

69 ing gas chromatography mass spectrometry (GC-MS), we identified compounds typically associated with p

70 chromatography-tandem mass spectrometry (GC-MS/MS) for GC-amenable pesticides; (ii) hydrophilic inte

71 The GC-MS component co-elution was overcome by GCxGC-qMS.

72 HS-SPME and LLE-GC/MS analyses revealed that metabolism of the compounds by

73 mpositions (C, H, N, O, S), Py-GC/FID, Py-GC/MS and SEM imaging reveal extensive degradation of the w

74 -gas chromatography/mass spectrometry (Py-GC/MS) and scanning electron microscopy (SEM).

75 ed using ICP-OES and volatiles using SPME-GC/MS.

76 on time to the scan duty cycle but generates MS/MS spectra rich in b/y-type and c/z(*)-type product i

77 rategy due to the reproducibility of the gum MS profile, even in the presence of other organic and in

78 The patients had MS for an average of 7.9 +/- 4.3 y (mean +/- SD), their

79 This online 2D-LC-HCD-MS/MS platform has high enrichment efficiency with 85% o

80 an (RR), hydrogen-deuterium exchange MS (HDX-MS) methods, and molecular dynamics (MD).

81 en/deuterium exchange mass spectrometry (HDX-MS) in the protein therapeutic field is undisputed; howe

82 en/deuterium-exchange mass spectrometry (HDX-MS) provides detailed insight into the structural dynami

83 en/deuterium exchange mass spectrometry (HDX-MS), fast photochemical oxidation of proteins (FPOP), al

84 Both HDX/MS and MD data showed that the metalation sites become m

85 by hydrogen exchange mass spectrometry (HDX/MS).

86 romatography-tandem mass spectrometry (HILIC-MS/MS) for polar pesticides, and; (iii) reversed-phase l

87 We acquired repeated down hole MS logging data in boreholes at a HC-contaminated field

88 However, MS-based disulfide mapping is challenged when multiple d

89 mprises methanol extraction followed by HPLC-MS analysis, and was able to identify 14 fungus secondar

90 A total of 16 flavonoids by HPLC-MS and 4861 genes exhibited significant differences at t

91 hromatography-tandem mass spectrometry (HPLC-MS/MS) method with multiple reaction monitoring (MRM) mo

92 scular to jugular vein were assessed by HPLC/MS/MS, and retention of the fat depot was monitored by M

93 HPTLC-MS of selected zones, eluted via the TLC-MS Interface in

94 LC-HR-MS typically produces a large amount of data for a singl

95 In conclusion, the new PSI-HR-MS/MS screening approach was suitable for comprehensive

96 resolution tandem mass spectrometry (LC-HRMS/MS).

97 ded myoglobin analyzed using conventional HX-MS, 97% coverage of the myoglobin sequence was still obt

98 its utility, we applied the correction to HX-MS excipient screening data collected for a pharmaceutic

99 have applied this fragment-based hyphenated MS technology to oligosaccharide standards and to de nov

100 r and I using the MIC method followed by ICP-MS determination were 0.039 and 0.015mugg(-1), respectiv

101 hereas Cd, As, Pb and Hg were assayed by ICP-MS.

102 o the development of this method, all LA-ICP-MS analyses of glacier ice involved a single element per

103 LA-ICP-MS analyses revealed element-specific ontogenetic variab

104 ely coupled plasma mass spectrometry (LA-ICP-MS).

105 s Spectrometry (ICP-MS), single-particle-ICP-MS (sp-ICP-MS), Transmission Electron Microscopy (TEM),

106 pectrometry (ICP-MS) and high-resolution ICP-MS, respectively.

107 ely coupled plasma mass-spectrometry (SP-ICP-MS) was used for the first time with a prototype data ac

108 try (ICP-MS), single-particle-ICP-MS (sp-ICP-MS), Transmission Electron Microscopy (TEM), Analytical

109 g inductively coupled mass spectrometry (ICP-MS) and high-resolution ICP-MS, respectively.

110 tively coupled plasma mass spectrometry (ICP-MS), amino acid analysis, and spectroscopy (ATR-IR, Rama

111 tively Coupled Plasma Mass Spectrometry (ICP-MS), single-particle-ICP-MS (sp-ICP-MS), Transmission El

112 yclotron resonance mass spectrometry (FT-ICR MS) and quantify DOM photochemical activity using probe

113 tron resonance mass spectrometry (21T FT-ICR MS).

114 yclotron Resonance-Mass Spectrometry (FT-ICR-MS), which delivered the molecular formulae and ion inte

115 ting from ion mobility-mass spectrometry (IM-MS) experiments provide a promising orthogonal dimension

116 , ESI-MS, ion-mobility mass spectrometry (IM-MS), AFM, and TEM.

117 ure-function relationships of drugs using IM-MS.

118 This enabled the novel LC-OzID-IMS-MS configuration where ozonolysis of ionized lipids occu

119 suggesting reduced amino acid catabolism in MS patients.

120 gonal dimension of structural information in MS-based analytical separations.

121 how smoking affects blood DNA methylation in MS patients, by assaying genome-wide DNA methylation and

122 on of miR-142-3p could be neuroprotective in MS.

123 er associated with the development of PML in MS patients treated with NTZ.

124 sition was significantly over-represented in MS compared to control cases in all compartments studied

125 Increased % MS signal intensity (SI) restoration of the peptide was

126 ersity of Notre Dame in South Bend, Indiana (MS), and finally Georgetown University, in Washington, D

127 njection of the HuR small-molecule inhibitor MS-444 in AOM/DSS mice, a model of IBD and inflammatory

128 zones, eluted via the TLC-MS Interface into MS, confirmed the identity of coumarin.

129 ric memory effect is further supported by IR-MS action spectroscopy and ab initio calculations.

130 This sSEC method is MS-friendly, robust, and reproducible and, thus, can be

131 JS-MS is publicly available with a GPLv2 license at github.

132 We present JS-MS, a 3-D, modular JavaScript client application for vie

133 in two Swedish cohorts, differing for known MS risk factors.

134 LC-MS-based metabolic phenotyping (metabotyping) in urine s

135 LC-MS/MS analysis of stem cell secretome revealed the prese

136 LC-MS/MS and proteomics analysis showed the production of m

137 Off-line 2D LC-MS/MS analysis (SCX-RPLC) of S. cerevisiae whole cell ly

138 A LC-MS method involving direct injection of extra-virgin oli

139 , and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-064

140 ecame the targets in the development of a LC-MS/MS method which underwent a rigorous in-house validat

141 LC-UV-Visible and LC-MS analyses showed that the fast reaction corresponds to

142 for 60min were identified using LC/MS and LC-MS/MS following monodimensional electrophoresis.

143 Integration of RNA-seq data from TCGA and LC-MS/MS proteomics from WS revealed an upregulation of ext

144 ctin-magnetic particle conjugate-assisted LC-MS/MS analyses.

145 ADG), rumen fluid metabolomic analysis by LC-MS and multivariate/univariate statistical analysis were

146 tion of phospholipids in data acquired by LC-MS and shotgun experiments.

147 Polyphenol compounds were identified by LC-MS-QTof and quantified by UPLC-PDA-FL.

148 the cross-linked product mycocyclosin by LC-MS.

149 total of 2565 proteins was identified by LC-MS/MS analysis (q-value </= 0.01) that accounted for 64%

150 1-dehydrocorticosterone) were measured by LC-MS/MS in maternal and cord plasma from 259 Caucasian wom

151 c acid, ten-fold dilution and analysis by LC-MS/MS using a pH 10 carbonate buffer.

152 45 different proteins were identified by LC-MS/MS.

153 Variation between this and a conventional LC-MS/MS method using authentic standards for calibration w

154 emcitabine treatment using iTRAQ labeling LC-MS/MS, because it was featured with the advantages of st

155 gh resolution MS (LC-HRMS), LC-tandem MS (LC-MS/MS) and nuclear magnetic resonance (NMR) spectroscopy

156 allow for pre- and postprocessing of raw LC-MS data.

157 A rapid and reliable LC-MS method for determining the triterpenic acids and dial

158 strategy for analysis of high-resolution LC-MS is also demonstrated.

159 liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-MS (GC-MS) data relative to l

160 liquid chromatography-mass spectrometry (LC-MS) for biomarker determination using ProGastrin Releasi

161 liquid chromatography-mass spectrometry (LC-MS) method to separate and quantify R- and S-9-PAHSA, an

162 liquid chromatography-mass spectrometry (LC-MS)-based detection of BPDE-N(2)-dG in BaP-treated roden

163 liquid-chromatography-mass spectrometry (LC-MS)-based metabolomics analysis of human biospecimens ha

164 chromatography tandem mass spectrometry (LC-MS/MS) was used for collection, identification, and quan

165 chromatography-tandem mass spectrometry (LC-MS/MS) were used to quantify volatile and ionic PFASs, r

166 chromatography-tandem mass spectrometry (LC-MS/MS) within the hydrolysates.

167 chromatography-tandem mass spectrometry (LC-MS/MS), (13)C6-metabolites were radiocalibrated by their

168 chromatography-tandem mass spectrometry (LC-MS/MS).

169 and high-throughput in comparison to the LC-MS based approach.

170 esults were highly comparable between the LC-MS platforms tested.

171 Furthermore, the LC-MS/MS and quantitative real-time-PCR analysis followed b

172 matrix effects, even for high-throughput LC-MS methods.

173 eased approximately threefold compared to LC-MS alone due to a combination of the reduction of chemic

174 tion on metabolome coverage in untargeted LC-MS metabolomics.

175 An untargeted LC-MS/MS platform was implemented for monitoring variations

176 observed directly in human samples using LC-MS techniques, even though sophisticated methodologies h

177 c acids, was performed by high-resolution LC/MS techniques.

178 liquid chromatography-mass spectrometry (LC/MS) techniques to investigate the role of glucose during

179 chromatography/tandem mass spectrometry (LC/MS-MS).

180 degrees C for 60min were identified using LC/MS and LC-MS/MS following monodimensional electrophoresi

181 Importantly, we show quantitatively with LC/MS analytics that the intracellular cargo release is con

182 The results were in highly agreement with LC/MS/MS which verified our method is extremely accurate.

183 Furthermore, LESA-MS was able to successfully differentiate between simple

184 ormation derived from chemical cross-linking/MS experiments.

185 , endo-beta-galactosidase coupled with MALDI-MS allowed these two epitopes, for the first time, to be

186 7 unique lipids identified by accurate mass, MS/MS spectral match, and retention times.

187 y tip links, and anomalous mechanosensitive (MS) channels on the top surface of the cells.

188 The role of mechanosensitive (MS) Ca(2+)-permeable ion channels in platelets is unclea

189 g for the investigation of mechanosensitive (MS) ion channels, since they are highly sensitive to the

190 d methodology employed the negative ion mode MS, included 44 authentic whiskies from diverse brands a

191 In the 24-month MS-STAT phase 2 trial, we showed that high-dose simvasta

192 ffect on labeled proteome analysis by nanoLC-MS(2), and demonstrate proof-of-principle applications o

193 Native MS detection was used to determine the sample oxidation

194 pectrometer, enabling high-resolution native MS analysis of 0.8- to 2.3-MDa prokaryotic 30S, 50S and

195 ffinity constant was determined using native MS, revealing a nearly eightfold enhancement in dimeriza

196 nsitive, respectively, than capillary LC-NSI/MS/MS assay of these adducts.

197 This SID nanoLC-NSI/MS/MS assay is highly sensitive and specific and it requ

198 lly acute and pathologically active cases of MS.

199 Using a combination of MS, isotope labeling, and (1)H and (13)C NMR techniques,

200 sis whereby the variability in the course of MS is driven by the very same pathogenic mechanisms resp

201 e and was elevated in cerebrospinal fluid of MS patients during relapse compared with specimens acqui

202 We conclude that nuclear localization of MS is a unique feature of respiratory yeasts such as P.

203 We used a murine model of MS, experimental autoimmune encephalomyelitis (EAE), to

204 uantification is only based on the number of MS(2) scans.

205 could be a clinically relevant predictor of MS development.

206 1-year increase in age at menarche, risk of MS was reduced by 13% (hazard ratio = 0.87, 95% confiden

207 omarker discovery studies, while the role of MS in translating biomarker candidates to clinical diagn

208 ound for zebrafish (Danio rerio), the use of MS-222 and benzocaine also appears to induce avoidance b

209 on of IL7R exon 6 splicing and its impact on MS risk.

210 After pediatric onset MS (POMS) diagnosis, age at onset younger than 15 years

211 bolites were investigated by LC/ESI-Orbitrap-MS in urine and finger nails collected from a Norwegian

212 ctivity underlie cognitive dysfunction in PP-MS, and that CLs possibly play a role in variability and

213 essive MS [SPMS], and 40 primary progressive MS [PPMS]) from C1 to T10.

214 emitting MS [RRMS], 17 secondary progressive MS [SPMS], and 40 primary progressive MS [PPMS]) from C1

215 Using LC/qTOF-MS we detected lumisterol, 20-hydroxylumisterol, 22-hydr

216 -time-of-flight-mass spectrometry (UPLC-QToF-MS).

217 lic compounds were identified by LC-PDA-QTOF/MS and quantified by UPLC-PDA-FL, as 26 anthocyanins, 9

218 vity detection and mass spectrometry (LC-RAD/MS).

219 and more rapid remyelination make relapsing MS more resilient than the progressive subtype.

220 Patients with relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS) with dis

221 V-1 (AC), 47 HAM/TSP, 74 relapsing-remitting MS [RRMS], 17 secondary progressive MS [SPMS], and 40 pr

222 Ten relapsing-remitting MS patients were studied using the TSPO radioligand (11)

223 l blood of patients with relapsing-remitting MS with a high disease score.

224 combination of HPLC-PDA, LC-high resolution MS (LC-HRMS), LC-tandem MS (LC-MS/MS) and nuclear magnet

225 The selectivities of high-resolution MS (HRMS) alone or in combination with all-ion-fragmenta

226 uantitative proteomics using high-resolution MS acquisition on the Orbitrap Elite and Orbitrap Fusion

227 were successfully quantified, and the SALDI-MS results obtained on the desalted serum sample spots s

228 olated syndrome (CIS) to multiple sclerosis (MS) and MS activity and disability.

229 ipheral nerve lesions in multiple sclerosis (MS) by magnetic resonance neurography (MRN).

230 Multiple sclerosis (MS) is caused by immune-mediated damage of myelin sheath

231 g white matter (NAWM) of multiple sclerosis (MS) patients using PET.

232 lar clinical features to multiple sclerosis (MS), but the international diagnostic imaging criteria f

233 e demyelinating disorder multiple sclerosis (MS), contributes to axonal dysfunction and neurodegenera

234 gical diseases including multiple sclerosis (MS), stroke, and Alzheimer's disease.

235 2A in an animal model of multiple sclerosis (MS), we administered blocking antibody to CLEC12A that s

236 ctivity in patients with multiple sclerosis (MS).

237 araparesis (HAM/TSP) and multiple sclerosis (MS).

238 n in selected ion monitoring mode (py-GC-SIM-MS).

239 Paired use of mass spectrometry (MS) for bacterial identification and automated-system-ba

240 iquid chromatography (LC)-mass spectrometry (MS) for the determination of their pharmacokinetic prope

241 alytical methods based on mass spectrometry (MS) have been successfully applied in biomarker discover

242 Mass spectrometry (MS) indicated that OM-MOSP interacts with proteins in ad

243 -somatropin); (ii) native mass spectrometry (MS) offered in-depth information, a substitution degree

244 /deuterium exchange (HDX) mass spectrometry (MS) reports on backbone H-bond fluctuations.

245 approximately 50 distinct mass spectrometry (MS) signals.

246 g with ambient ionization mass spectrometry (MS) was developed.

247 Despite the ubiquity of mass spectrometry (MS), data processing tools can be surprisingly limited.

248 Here, we used a mass spectrometry (MS)-based approach to map the complete glycosylation pro

249 cids, here we used modern mass spectrometry (MS)-based techniques to separate and sequence de novo pr

250 ce (NMR) spectroscopy and mass spectrometry (MS).

251 s relies mainly on tandem mass spectrometry (MS/MS) analysis.

252 ins lymphoid aggregates, called milky spots (MSs), that contribute to peritoneal immunity by collecti

253 ld be taken out and analyzed by direct spray MS of the biosensor chip to confirm the identity of DON.

254 Tandem MS/MS experiments showed that DMSO could modify the diss

255 , LC-high resolution MS (LC-HRMS), LC-tandem MS (LC-MS/MS) and nuclear magnetic resonance (NMR) spect

256 of cold-ion spectroscopy coupled with tandem MS may render this the key technology to unravel complex

257 A novel targeted MS-based method is developed to increase the likelihood

258 uantified in rumen and plasma using targeted MS to validate and evaluate the simple combination of me

259 Although the temporal MS response at this site gives valuable field-scale evid

260 The MS data were analyzed in conjunction with redox conditio

261 The MS response at the site diminished during the sampling p

262 The MS/MS spectra of the peroxy acids showed fragmentation p

263 ction of antifungal resistance, although the MS-AFST assay performed at 3 h of the in vitro antifunga

264 that platelets and Meg-01 cells express the MS cation channel Piezo1, which may contribute to Ca(2+)

265 We now describe the results of the MS-STAT cognitive substudy, in which we investigated the

266 nant analysis (PLSDA), were performed on the MS and Raman spectral data, along with a variety of spec

267 rom either source had the same effect on the MS-CPET rate constants, and a combined Bronsted plot of

268 d for PSI was lower, and the distance to the MS orifice over which spray could be obtained was larger

269 roplets and ions and directing it toward the MS inlet.

270 TLC-MS of selected zones, eluted via the TLC-MS Interface into MS, confirmed the identity of coumarin

271 spray ionization (PSI) technique coupled to MS might overcome these steps by direct analysis of comp

272 We propose that targeted delivery of GD1a to MS lesions may act as a potential novel molecular tool t

273 ites, while specificity and NPV of MALDI-TOF MS for males were significantly higher than those for fe

274 demonstrate the value of this new MALDI-TOF MS method as an analytical tool for the identification o

275 S intervention included: real-time MALDI-TOF MS pharmacist notification and prospective AMS provider

276 rption ionization-time of flight (MALDI-TOF) MS organism identification and automated-system-based an

277 basis of the additional dimension of ESI-TOF-MS.

278 e-of-flight mass spectrometry (LAESI-IMS-TOF-MS) was used for the analysis of synthetic polymers and

279 Additionally, MALDI-ToF-MS indicates the polymerization of glyoxal/glyoxylic aci

280 ase in pressure compared to standard PTR-TOF-MS.

281 zation time-of-flight mass spectrometry (TOF-MS) allows the detection of thousands of compounds.

282 A GCxGC-TOF/MS method was set up for the multiresidue analysis of 18

283 In this study, the TWIM-MS technique was used to separate isomeric Au(I) metallo

284 aphy tandem mass spectrometry (MAE-SPE-UHPLC-MS/MS).

285 romatography-tandem mass spectrometry (UHPLC-MS/MS) for low to medium polarity pesticides.

286 liver and muscle bovine tissues using UHPLC-MS/MS.

287 The MISPE method was validated by UPLC-MS/MS for the determination of AOH and AME in tomato jui

288 hat enzyme-free heat treatment prior to UPLC-MS/MS analysis gives better sensitivity and reduces chro

289 Analysis of fractions of STP-C1 using UPLC-MS/MS identified sixteen peptides/amino acids.

290 id [PCA] and urocanic acid [UCA]) using UPLC-MS/MS, transepidermal water loss (TEWL) and epidermal pH

291 ar JavaScript client application for viewing MS data.

292 mechanical tunneling, multistructural VTST (MS-VTST), multi-path VTST (MP-VTST), both reaction-path

293 hin the source zone to better assess whether MS can serve as a proxy for monitoring HC contamination

294 DL may reflect core mechanisms through which MS components develop and progress in parallel with insu

295 17 patients with MS and 11 healthy controls (HCs) underwent 3 experimenta

296 ive TH1/TH17CM cells expand in patients with MS and promote relapses after bystander recruitment to t

297 .82; P < .001) were reduced in patients with MS compared with healthy controls.

298 The 7,292 patients with MS were matched individually with 10 people without MS b

299 yelin-derived self-antigens in patients with MS.

300 matched individually with 10 people without MS by sex, year of birth, age/vital status at MS diagnos